GRFS News 38.17 Grifols S.A. (GRFS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Grifols S.A. (GRFS) 38.17 $GRFS

Strength Seen in Apricus Biosciences (APRI): Stock Soars 18.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 8:04AM CDT
Apricus Biosciences, Inc. was a big mover last session, as the company saw its shares rise almost 19% on the day.

Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia
PR Newswire - Thu Apr 17, 7:47AM CDT
Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) today announced that it will donate up to 20 million units of coagulation therapies in each of the next three (3) years to the World Federation of Hemophilia (WFH). Grifols has been a proud supporter of the WFH and its noble efforts for nearly a decade - and this unprecedented product donation represents its largest commitment to date. According to the WFH, this donation of blood clotting factor products will secure an average of 40,000 doses to treat approximately 10,000 patients in developing countries worldwide through 2017, where access to adequate treatment is often lacking or absent.

Stocks Fade From Fresh Session High
at Investor's Business Daily - Wed Apr 16, 12:55PM CDT
Stocks eased Wednesday afternoon after briefly pushing to new session highs on reassuring comments by Fed Chairwoman Janet Yellen. The Nasdaq and the Dow Jones industrial average were each up 0.6%, while the S&P 500 rose 0.5%. Volume continued to...

Flamel Technologies (FLML) in Focus: Stock Slumps 13.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 7:54AM CDT
Flamel Technologies (FLML) fell nearly 14% in the last trading session amid high volumes, continuing its recent volatile trend as it is currently trading within the volatile price range of last one month.

Pharmacyclics (PCYC) Crumbles: Stock Falls by 7.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 10:00AM CDT
Pharmacyclics’ shares fell by nearly 8% yesterday, continuing its downtrend in the past one-month time frame.

Facebook, Arris, Grifols Initiate New Bases
at Investor's Business Daily - Fri Apr 11, 5:35PM CDT
With the stock market in a correction, the investor should emphasize defense. This means keeping cash in the portfolio, cutting losses on any stocks that are falling fast, and taking at least some profits on stocks that trigger key sell signals....

PharmAthene (PIP) Crumbles: Stock Falls by 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 7:51AM CDT
PharmAthene saw a big move last session, as the company’s shares fell by over 7% on the day

Global Critical Care Market 2013-2019
M2 - Fri Apr 11, 2:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/prjqh7/critical_care) has announced the addition of the "Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific" report to their offering. The overall critical care therapeutics market was worth $2.3 billion in 2012, having grown in size at a CAGR of 11% from $1.2 billion in 2006. The market is expected to grow at a CAGR of 5% to reach $3.2 billion in 2019. The double-digit market growth registered between 2006 and 2012 can be attributed primarily to the increased demand for and cost of albumin, as well as the approval and launch of new products. The report analyzes the markets for factor XIII concentrates, fibrinogen concentrates, albumins, antithrombins and prothrombin complex concentrates in the US, the top five countries of Europe (the UK, Germany, France, Italy and Spain), and Japan. The report does also provide an overview on Asia-Pacific countries, including China, India and Australia. The report provides an overview of major marketed products in critical care market along with treatment usage patterns, average annual cost of therapy and market forecast to 2019 for key geographical markets, as well as for leading therapeutic segments. The report also provides information on the Research and Development (R&D) product pipeline and explores the competitive landscape, including the provision of profiles for major players in the critical care market. Finally, the report includes analysis of Mergers and Acquisitions (M&A) activity in the critical care market. The growth of the overall critical care market during the forecast period is expected to be largely due to an increasing preference in the market for factor concentrates such as Riastap, Corifact, rFXIII (which has been launched in the EU and is expected to be launched in the US later this year), the expanded indication for Antithrombin (AT) III and factor concentrates, and rising demand for albumin from countries in the Asia-Pacific region. Stagnant innovations, a low prevalence rate and the consequent limited availability of patients are some of the factors impeding the growth of the critical care market. Key Topics Covered: - Tables & Figures - Introduction - Critical Care Market to 2019 - Global Overview - Critical Care Market to 2019 - Geographical Landscape - Critical Care Market to 2019 - Albumin Market - Critical Care Market to 2019 - Antithrombin Concentrate Market - Critical Care Market to 2019 - Fibrinogen Concentrate Market - Critical Care Market to 2019 - Prothrombin Complex Concentrate Market - Critical Care Market to 2019 - Factor XIII Concentrate Market - Critical Care Market to 2019 - Research and Development Product Pipeline - Critical Care Market to 2019 - Competitive Landscape - Critical Care Market to 2019 - Strategic Consolidation - Critical Care Market to 2019 - Appendix Companies Mentioned - Baxter International Incorporated - Bio Products Laboratory Limited - Biotest - China Biologic Products, Incorporated - CSL Limited - Grifols, SA - Hualan Biological Engineering, Incorporated - Kedrion SpA - aboratoire Fran?ais de Fractionnement et de Biotechnologies - Octapharma AG - Sanquin Blood Supply Foundation - Shanghai RAAS Blood Products Company, Limited For more information visit http://www.researchandmarkets.com/research/pr...tical_care

Fluor-Designed and Built Plasma Fractionation Facility Awarded ISPE 2014 Facility of the Year for Project Execution
Business Wire - Thu Apr 10, 3:37PM CDT
Fluor Corporation (NYSE: FLR) announced today that Grifols' North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year for Project Execution.

Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 8:21AM CDT
Pacira Pharmaceuticals, Inc. (PCRX) was a big mover last session, as the company saw its shares rise by over 11% on the day.

Stocks Rally, Stall, Turn Mixed; Consol Energy, U.S. Steel Jump
at Investor's Business Daily - Tue Apr 08, 9:29AM CDT
Early gains quickly flickered into a mixed performance Tuesday, with China-based stocks grabbing a large share of early gains. The Nasdaq bobbed to a 0.2% gain. The S&P 500 eased 0.1%. The Dow Jones industrial average dipped 0.2%. Volume was mixed,...

Stocks Weaken In Late Trade; Questcor Pares Gains
at Investor's Business Daily - Mon Apr 07, 1:57PM CDT
Stocks continued to worsen in late trading Monday and were on pace for a third straight loss. The Nasdaq slumped 1.7% to a two-month low. The S&P 500 dropped 1.2%, putting it near its 50-day line. Meanwhile, the Dow Jones industrial average lost 1%....

Major Averages Face More Selling, Biotechs Rally Back
at Investor's Business Daily - Mon Apr 07, 11:01AM CDT
Stocks were under pressure and near session lows about two hours into Monday's session. Biotechs bucked the trend, rallying back after recent weakness. The Dow Jones industrial average lost 0.6%, while the Nasdaq and S&P 500 fell 0.5%. Nasdaq volume...

Annual Report for 2013 on Form 20-F filed with the SEC on April 4, 2014
PR Newswire - Fri Apr 04, 10:54AM CDT
Grifols, S.A. ("Grifols" (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), announced that it has filed its 2013 Annual Report on Form 20-F with the United States Securities and Exchange Commission ("SEC" on April 4, 2014. Grifols' Annual Report on Form 20-F includes its audited financial statements for its fiscal year ended December 31, 2013.

Salix Among Stocks Getting Support At 10-Week Line
at Investor's Business Daily - Thu Apr 03, 5:13PM CDT
A number of leading stocks in Your Weekly Review are in a secondary buy range amid the market's renewed uptrend. Stocks in the highly rated Medical-Ethical Drugs industry again led this week's list, which expanded to 109 members after shrinking to...

Four Top World Stocks Offer Follow-On Buy Points
at Investor's Business Daily - Wed Apr 02, 5:11PM CDT
The market's resumed uptrend doesn't come with the clean slate that a sharp correction followed by a follow-through day would offer. A striking eight distribution days levied against the Nasdaq hold out a bright red flag for investors. But the shift...

Stocks Hold Near Highs; Heartland Keeps On Trucking
at Investor's Business Daily - Mon Mar 31, 1:57PM CDT
The major averages were holding near session highs late Monday afternoon, buoyed by dovish comments from Federal Reserve chief Janet Yellen. The Nasdaq was up 1.2%, the Dow Jones industrial average 0.9% and the S&P 500 0.8%. However, volume was...

Concise Analysis of the International Cell Surface Markers Market - Forecasts to 2018
M2 - Mon Mar 31, 5:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xkhjg7/cell_surface) has announced the addition of the "Concise Analysis of the International Cell Surface Markers Market - Forecasts to 2018" report to their offering. Cell surface markers are unique to cell types and have vital functional role in immunology. These are generally antigens or molecules present within the plasma membrane of the cell. Such markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents Chapter 5 Global Cell Surface Markers Market, by Applications Chapter 6 Global Cell Surface Markers Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - BD Biosciences - Beckman Coulter, Inc - Bio-Rad Laboratories, Inc - F Hoffmann-La Roche Ltd - Grifols SA - Immucor, Inc - Janssen Diagnostics, Inc - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/xk...ll_surface

Stock Futures Aim Firmly Higher: Visa Slips On Wal-Mart Lawsuit
at Investor's Business Daily - Fri Mar 28, 8:03AM CDT
Stock futures pushed higher ahead of Friday's open, looking to continue the week's trend of positive starts. Dow futures were 32.7 points above fair market value and on the rise. Nasdaq 100 futures were also rising, up 14.2 points. S&P 500 futures...

Endocyte (ECYT) in Focus: Stock Tumbles 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 7:47AM CDT
Endocyte, Inc. (ECYT) saw a big move last session, reversing the recent trend for ECYT as the stock is now up more than 75.0% in the past one-month time frame.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 108

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 7

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 87

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 22

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
NCPDP Elevates J.W. Hill to President & COO Role

Updated Category News Views 9

Plotting the Course for NCPDP's Future Today's shakeup at the NCPDP has got the sector's ears perked. For those who don't speak in acronym soup all day—NCPDP stands for National Council for Prescription Drug Programs. They're the brains behind many crucial healthcare standards, improving information flow around meds, supplies, and services. Now, they're taking bold...

Continue Reading
Cinmoore's Smart Camera: A Game Changer for Car Security

Updated Category News Views 43

Pioneering Car Security with Cinmoore's Smart Camera Ever left your car in the parking lot, heart pounding, wondering if it's safe while you run errands? Well, Cinmoore might just quell that parking paranoia with their new gizmo, the Smart Parking Camera DC1U. This device isn't just some fancily-packaged disappointment—it promises some serious peace of mind for those...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 211

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 0

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 110

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 22

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading

Top 5 Most Recently Viewed Articles

Warren Buffett's Wisdom: Rethinking Your Stock Strategy

Updated Category News Views 155

Billionaire investor Warren Buffett became a titan in finance through his distinctive approach to stock investing, one that flips conventional wisdom on its head. While most folks lose their heads when prices drop, Buffett sees opportunity. When stocks go down, he doesn’t cry; he gets excited. "I love it when the things we buy go down," he said in a reflective moment...

Continue Reading
Kenneth L Calloway's $452K Share Sale: What It Means for CENX

Updated Category News Views 220

Understanding the Recent Insider Trade in Century Aluminum In a notable move that has caught the attention of investors, Kenneth L Calloway, the Senior Vice President at Century Aluminum, recently sold a significant amount of stocks. The transaction, which took place recently and is detailed in an SEC filing, involved the sale of 16,450 shares valued at approximately...

Continue Reading
Jura Energy Corporation Releases Key Financial Information

Updated Category News Views 213

Jura Energy Corporation Financial Filings Overview Jura Energy Corporation has recently announced an important update regarding its financial performance. The company has filed its condensed consolidated interim financial statements for the periods ending June 30 for both 2025 and 2024 on SEDAR. Alongside these financial statements, Jura has also released its...

Continue Reading
Exploring the Surge in Edge Computing Growth and Its Impact

Updated Category News Views 207

Understanding Edge Computing Growth Dynamics The edge computing market is poised for significant growth, projected to increase by USD 19.6 billion during the period between 2024 and 2028. This advancement is primarily fueled by the rising demand for decentralized computing, aimed at minimizing latency in decision-making processes. Technological advancements heralding...

Continue Reading
Hiab's Q3 Report 2025: Navigating Challenges with Resilience

Updated Category News Views 239

Hiab's Financial Journey in Q3 2025: An Overview Hiab's latest quarterly report sheds light on the company's performance amidst swirling market uncertainties. The recent challenges stemmed primarily from lower sales figures in parts of their market, particularly in the United States, affecting profitability. Key Highlights of the Quarterly Performance The first major...

Continue Reading